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Summary  
 
Background  Smoking, sedentary lifestyle and obesity are risk factors for mortality and 
dementia. However, their impact on cognitive impairment free life expectancy (CIFLE) has 
not previously been estimated.  
Methods  Data were drawn from the DYNOPTA dataset which was derived by harmonizing 
and pooling common measures from five longitudinal ageing studies. Participants for whom 
Mini-Mental State Examination (MMSE) was available were included (N=8111, 48.6% 
men). Data on education, sex, BMI, smoking, and sedentary lifestyle were collected and 
mortality data obtained from Government Records via data linkage.  Total life expectancy 
(LE), CIFLE and years spent with cognitive impairment (CILE) were estimated for each risk 
factor and total burden of risk factors. 
Results CILE was approximately 2 years for men and 3 years for women, regardless of age.  
For men and women respectively, reduced LE associated with smoking was 3.82 and 5.88 
years, associated with obesity was 0.62 and 1.72 years, and associated with being sedentary 
was 2.50 and 2.89 years. Absence of each risk factor was associated with longer LE and 
CIFLE, but also longer CILE for smoking in women and being sedentary in both sexes.  
Compared to participants with no risk factors, those with 2+ had shorter CIFLE of up to 3.5 
years depending on gender and education level.  
Conclusions Population level reductions in smoking, sedentary lifestyle and obesity increase 
longevity and years lived without cognitive impairment. But not all years lived are free of 
cognitive impairment and CILE may also increase. 
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Introduction 
 As life expectancy (LE) continues to increase globally, there is an urgent need to 
establish that increased years of life are spent in good health. Health expectancies (HE) are a 
broad set of population health indicators that combine information on morbidity and mortality 
(1). They were developed to address the question of whether the extra years of LE are healthy 
ones and to provide a metric for the compression of morbidity (2, 3). 
 As age is the strongest risk factor for dementia (4), increasing LE will result in a 
greater number of older adults with dementia. In the context of HE research, there have been 
more estimates based on cognitive impairment rather than dementia, mainly due to data 
availability. Typically the Mini-Mental State Examination (MMSE) is used to define 
cognitive impairment (5) and this instrument has been widely validated as a screening 
instrument for dementia (6). Previous research from Europe (7-9), Canada (10) and the 
United States (11, 12) has shown that on average, approximately 5 to 10% of life after age 65 
is spent with cognitive impairment  
 Given the lack of treatment or cure for dementia, there has been focus on primary and 
secondary prevention through risk reduction. Although not entirely uncontroversial (13), it 
has recently been estimated that a 10-25% reduction in seven key risk factors could prevent 
1.1-3.0 million Alzheimer’s disease (the largest cause of dementia) cases internationally (2). 
A crucial issue therefore for public health policies is the extent to which cognitive 
impairment free life expectancy (CIFLE) can be extended, and years with cognitive 
impairment (CILE) can be shortened, through reducing risk factors associated with late-life 
dementia. Three key modifiable risk factors for dementia that have recently been the focus of 
modelling of dementia risk reduction include smoking (14), sedentary lifestyle (15, 16) and 
obesity (17).  Current smoking has been associated with approximately 80% increased risk of 
dementia (14), whilst a sedentary life style or engaging in no physical activity is associated 
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with around 25% increased  risk of dementia compared to engaging in some (18). Overweight 
and obese body mass index (BMI) in midlife (40 to 60 years), have been associated with a 
26% and  64% increased risk of dementia in late-life, respectively (19) although the risk 
associated with late life obesity and overweight  is less clear. To our knowledge there has 
been no previous investigation of the influence of these risk factors on cognitive impairment-
free life expectancy (CIFLE). 
 To date the main focus of research on has been on social inequalities in CIFLE, 
specifically education as a proxy for socio-economic status (9), reflecting social inequalities 
in broader measures of healthy LE (20). Low levels of education have been associated with 
increased risk of dementia (21) and more years of life lived  with cognitive impairment (9, 
11).  Low education is a marker of low socio-economic status, and this is also associated with 
a greater number of health risk behaviours (22) so may act as a proxy for these, in addition to 
reflecting educational opportunities that may influence opportunities to develop cognitive 
reserve (23). 
 The present study aimed to explore the extent to which three modifiable risk factors 
for dementia, specifically smoking, sedentary lifestyle, and obesity, affected LE with and 
without cognitive impairment in Australian men and women, and taking account of 
educational level.  
 
Method 
Sample 
 The sample was drawn from DYNOPTA, a pooled dataset of Australian Longitudinal 
Studies (24).  For this study, contributing DYNOPTA studies had to include a common 
cognitive outcome measure and data on mortality. The contributing studies included The 
Australian Longitudinal Study of Ageing (ALSA)(25), the Blue Mountains Eye Study 
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(BMES)(26), the Canberra Longitudinal Study (CLS)(27), the Sydney Older Persons Study 
(SOPS)(28), and the Path Through Life Study (PATH)(29).  ALSA  is a random sample 
drawn from the city of Adelaide in South Australia. BMES  is a random sample drawn from 
the Blue Mountain region in New South Wales (NSW), encompassing two post code areas, 
and is the only study to sample a semi-urban population that is not from a capital city. CLS  
comprises a random sample drawn from the city of Canberra. SOPS comprises a random 
sample drawn from the inner-city of Sydney, NSW. PATH comprises a random sample 
drawn from Canberra and Queanbeyan, NSW. The age-ranges and occasions of measurement 
for each study are reported in Table 1. For all studies, participants were excluded from 
analyses if they did not provide MMSE data at baseline and most of these cases did not have 
MMSE data at later waves. The total sample comprised 8111 participants (3947 males). 
 
Measures 
MMSE was used to assess probable cognitive impairment (30).  A cutpoint of 23/24 
(MMSE score ≤ 23 = ‘probable dementia’; MMSE score > 23 = ‘no cognitive impairment’) 
was used as a proxy for dementia status as reported previously (31). Clinical diagnoses of 
dementia were available for two contributing studies and the 23/24 cut point yielded the 
optimal sensitivity and specificity for probable dementia  which were 93.06% (CI: 90.66-
94.89%) and 70.20% (CI: 69.09% to 71.28%) respectively (31). To enable comparison of LE, 
CIFLE and CILE by education with the Medical Research Council Cognitive Function and 
Ageing Study (MRC-CFAS), analyses were also conducted with a cutpoint of 21/22(9).   
Level of education was coded as a binary variable with those leaving school before 15 
years classified as ‘Early school leavers’ (ESL) and those leaving school aged 15 or older 
classified as ‘Late school leavers’ (LSL).  The choice of education variables was determined 
by the need to harmonize education across multiple studies. In Australia during the time of 
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the cohorts studied, a major exit point from school occurred after 9 years of schooling, at age 
14 (32).  Baseline smoking status was coded as current, former and never smoker. Self-
reported frequency of walking sessions per week was used as a measure of physical activity, 
with sedentary behaviour defined by less than one walking session per week. Obesity was 
defined by a BMI of 30 or greater. 
 
Statistical analyses 
To assess the impact of health behaviours on cognitive impairment and death through CIFLE 
we fitted a continuous time multistate model with three states: no cognitive impairment, 
cognitive impairment, and death (absorbing state). This model estimated the instantaneous 
rate of transition (transition intensities) between the states, making the assumption that 
transition from cognitive impairment to no cognitive impairment was not possible (illness-
death model), and therefore any observed transitions were due to recording error. We did not 
assume that transition intensities were constant across observed time intervals, but used a 
piecewise-constant intensity model with time from entry to the study as the timescale and age 
as an external time-dependent covariate, capturing the time-dependency of the intensities 
(33).  We assessed the best fitting model, in terms of the length of time over which the 
intensities are assumed constant, by a likelihood ratio test between a constant intensity model 
and the piecewise-constant intensity. This resulted in the best-fitting time breakpoint being 
six months.  The methodology analysing panel data using continuous-time multistate models 
with interval censoring has been around for many years (34, 35) and more recently the msm 
package for the R statistical software (36) has been developed to allow these models to be 
fitted in a flexible framework.  To calculate life expectancies in different states we utilised 
the estimates from the piecewise-constant transition intensity matrix and used the method 
outlined by van den Hout and Matthews (33) with 1000 replications to produce mean 
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estimates of total LE, CIFLE and CILE (with corresponding standard errors) by sex, 
education and each health behaviour.  Models were first fitted for each health behaviour 
individually, and then combined into a single score (0, 1, 2+ unhealthy behaviours); all 
models were adjusted for education and stratified by sex. Where data were missing on 
covariates (health behaviours or education) they were excluded Participants with missing 
information on cognitive state (other than the first observation) were retained and treated as 
censored. Data were weighted to reflect the estimated resident population of Australia in 
1996.  
 
Results 
Description of sample 
 Table 2 shows the number of men and women in the sample at each follow up 
according to cognitive impairment status.  At baseline 94.2% of men and 95.1% of women 
had no cognitive impairment, 34.7% of men and 33.3% of women left school at or before the 
age of 14,10.7% of men and 8.5% of women were smokers, 23.2% men and 27.0% women 
were sedentary and 11.2% men and 15.7% women were obese.  
 
Overall life expectancies with and without cognitive impairment for men and women 
 The estimated years lived with CILE increased slightly with age (Figure 1) and 
formed a much greater proportion of remaining LE with increasing age (Supplementary Table 
1). Whilst men aged 65 spent 1.87 years (10.9%) of their remaining 17.04 years with 
cognitive impairment, by age 85 the estimated number of years with cognitive impairment for 
men rose slightly to 2.13 years and this amounted to 37.7% of remaining life (5.6 years) 
(Supplementary Table 1). Compared to men, women spent longer with cognitive impairment 
at all ages, though given their longer LE, a similar proportion of remaining life was spent 
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with cognitive impairment; 2.95 years (13.9% of  remaining 21.1 years) at age 65 and 3.09 
years (39.5% of LE) at age 85. Comparison of estimates using a cutpoint of 21/22 on the 
MMSE (see supplementary Table 2) with MRC-CFAS showed similar relatively constant 
years with CILE regardless of age though years spent with cognitive impairment in MRC-
CFAS were fewer for men (around 1.4 years) and higher in women (around 2.5 years).   
 
Years with and without cognitive impairment for individual health risk factors 
 CIFLE and CILE are reported by each health risk factor individually in Table 3 (high 
education) and Supplementary Table 3 (low education).  When the three health factors in 
high educated individuals were viewed separately, smoking was associated with the most 
years of life lost. At age 65 male smokers lived 3.82 years (SE 0.74 years) less than male 
non-smokers (p<0.0001) whilst for females the difference was 5.88 years (SE 0.97 years, 
p<0.0001). Compared to non-smokers, CIFLE at age 65 for male smokers was 2.95 years (SE 
0.70 years) less and for female smokers 4.60 years (SE 0.90 years) less (both p<0.0001). 
However, non-smokers were estimated to live for longer with cognitive impairment in both 
absolute (years) and relative terms (proportion of total LE).  The difference in CILE between 
non-smokers and smokers was just under one year for men (p=0.05) and just over one year 
for women (p=0.02). 
 The difference in LE at age 65 between obese and non-obese participants was small 
(men: 0.62 years, SE 0.94 years, p=0.51; women: 1.72 years, SE 0.93 years, p=0.06). 
Similarly obesity conferred only a small reduction in CIFLE at age 65   (men: 0.94 years, SE 
0.79 years, p=0.23; women: 1.11 years, SE 0.90 years, p=0.22) and in years with cognitive 
impairment (Table 3).  Finally, those physically active, sedentary men and women had 
shorter LE at age 65 (men: 2.50 years, SE 0.74 years, p=0.0007; women: 2.89 years, SE 0.89 
years, p=0.001) and significantly shorter CIFLE for men but not women (men: 1.54 years, SE 
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0.70 years, p=0.03; women: 1.15 years, SE 0.76 years, p=0.13). On the other hand, due to the 
gain in LE, expected years lived with cognitive impairment at age 65 was significantly 
greater for the physically active (men: 0.95 years, SE 0.42 years, p=0.02; women: 1.73 years, 
SE 0.58 years, p=0.002) (Table 3). 
 Although all life expectancies were lower in those with lower education compared to 
the higher education group, the differences between those with and without good health 
behaviours were similar and thus conclusions were the same with respect to their associations 
with CIFLE and CILE. 
 
Cognitive health expectancies for levels of risk factor burden 
 To evaluate the association between risk factor burden and HE outcomes, we created 
a combined score with 0, 1, or 2+ risk factors. LE, CIFLE and CILE at age 65 were all 
significantly greater for individuals with zero risk burden compared to those with 2+ risk 
factors. For LE this amounted to a gain of over 4 years for men and over 5 years for women, 
with the greatest gain for women with lower education (5.94 years). For CIFLE there were 
gains of between 3.0 and 3.5 years. Compared to those with 2+ risk factors, men with no risk 
factors had around one year more of CILE regardless of level of education, whereas women 
with no risk factors and lower education gained more years with cognitive impairment (2.46 
years, SE 0.74 years) than those with higher education (1.56 years, SE 0.49 years) (Table 4). 
 
Discussion 
 The present study is the first to evaluate the impact of smoking, sedentary lifestyle 
and obesity on CIFLE and several important results emerged. First, risk factors vary in the 
extent to which they are associated with both increased LE and reduced CIFLE, and also vary 
by gender, thus presenting a complex picture of the overall impact of risk factors on CIFLE. 
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Consistent with the wider literature, smoking conferred the largest reduction in CIFLE for 
men and women did not show much variation between higher and lower education groups.  
Overall the findings here suggest that risk reduction will delay the onset of cognitive 
impairment or dementia, but not necessarily prevent it. On the contrary, risk reduction will 
increase longevity and some will also increase years of life spent with cognitive impairment.  
 In the present study, while smoking and sedentary lifestyle had the expected negative 
effects on LE and cognitive impairment, the findings for obesity were more complex, 
particularly for men. This was not entirely unexpected as previous literature has failed to find 
increased risk of dementia associated with obesity in late life (37). However it is possible that 
results for obesity are confounded by methodological limitations. BMI declines in the 6 years 
prior to diagnosis with dementia (38) and hence in studies of older adults where such 
participants are retained in the sample, the effect of high BMI will not be identifiable. A 
limitation with this literature has been the use of a continuous BMI measure, whereas the 
research on mid-life obesity has demonstrated an inverse-U-shaped association between 
categories of BMI and late-life dementia risk (17).  On the other hand, there is also the 
‘obesity paradox’ (39) in which obesity has been associated with better survival in some 
clinical groups.   
 In the broader literature on dementia risk reduction, the combined population 
attributable risk of risk factors for dementia has been used to produce estimates of the number 
of cases of dementia that could be prevented by removing these key risk factors (40-42). 
Some authors using this method have assumed that the risk factors are additive when using 
combined risk scores to estimate the potential to reduce dementia prevalence (41).  However,  
it is likely that the current modelling in this domain may be overly optimistic because it has 
been conducted without consideration of competing risk (43) caused by risk reduction, 
namely increased longevity (44). Age is one of the strongest risk factors for dementia (4, 31), 
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and common cardiovascular risk factors for dementia are also associated with increased 
mortality risk, in both younger adulthood (45) and late adulthood (46).   
 The current study has implications for the increasingly important area of statistical 
modelling of the impact of dementia risk reduction on future prevalence. Our findings relate 
to years of cognitive impairment at the population level, and do not estimate number of cases 
of dementia. Nevertheless, cases of dementia and years lived with cognitive impairment are 
two dimensions of the same phenomenon. Our findings suggest that previous modelling of 
the potential to reduce the impact of dementia through risk reduction using population 
attributable risk of individual risk factors may be exaggerated because they do not take into 
account that increased longevity (resulting from risk reduction) is associated with increased 
dementia risk (40, 41).  The results presented here are not projections, but are drawn from 
actual data from individuals in cohort studies and hence are less subject to bias. Our findings 
of a relatively constant number of years with cognitive impairment, regardless of age, 
confirm others, though study differences in the absolute number of years may reflect cohort 
differences in education.   
 The results of the present study need to be interpreted in the context of its limitations. 
All data on risk factors were obtained by self-report. Data were not drawn from nationally 
representative samples, but all contributing datasets were population-based and representative 
of the region from which they were drawn, and sample weights were available to adjust 
estimates to represent the Australian population. There was an under-representation of adults 
living in residential facilities. The study did not take into account known genetic risk factors 
for dementia such as the Apolipoprotein E genotype because these data were not 
available(47). Our analysis has focussed on LE without cognitive impairment and this is not 
the same as HLE, since individuals may be free of cognitive impairment but have other 
conditions. This study also had several strengths including a large sample size. The statistical 
13 
 
models used allowed for covariates and hence risk factors could be examined after adjusting 
for education which has not been done previously. Modelling was conducted on longitudinal 
data that had been linked to the national death registry. The MMSE has been used in previous 
studies of CIFLE and hence allows the results of this study to be compared with findings 
from other countries (9). 
 Our findings clearly support the view that risk reduction will delay incident dementia. 
However, the impact on life spent with cognitive impairment is less clear. Longevity itself 
increases the risk of cognitive impairment, so there appears to be somewhat of a longevity 
paradox with dementia risk reduction.
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Table 1: Characteristics of the Contributing Studies in DYNOPTA 
 
ALSA BMES CLS PATH SOPS 
Baseline Year 1992 1992 1990 2001 1991 
MMSE  wave 1 
date 1992 1997-2000 1990 2001-2002 1991-1993 
 age range 65-103 59-99 70-100 60-66 75-98 
n 2008 1962 994 2547 600 
MMSE  wave 2 
date 1994-1995 2001-2004 1994 2005-2006 1994-1996 
 age range 67-106 65-100 74-102 64-70 78-99 
n 1542 1410 629 2185 426 
MMSE  wave 3 
date 2000-2001 1998 1997-1999 
 age range 73-102  78-102  81-101 
n 652 371 271 
MMSE  wave 4 
date 2003-2004 2002 2001-2003 
 age range 76-102  82-106  84-106 
n 406 209 56 
 
ALSA: The Australian Longitudinal Study of Ageing; BMES: The Blue Mountains 
Eye Study; CLS: The Canberra Longitudinal Study; PATH: The Personality and Total 
Health Through Life Study; SOPS: The Sydney older persons Study
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Table 2: Sample profile 
Males (n = 3947) Females (n = 4164) 
Years in 
Study  
No 
Cognitive 
impairment 
Cognitive 
Impairment 
Deceased 
(cumulative) Missing 
No 
Cognitive 
impairment 
Cognitive 
Impairment 
Deceased 
(cumulative) Missing 
M (SD)   N  (%) N  (%) N  (%) N  (%) N  (%) N  (%) N  (%) N  (%) 
Baseline - - 3718 94.2 229 5.8 - - - -   3962 95.1 202 4.9 - - - - 
ALS ≤ 14 - - 1225 31.0 147 3.7 - - - - 1265 30.4 119 2.9 - - - - 
ALS > 14 - - 2482 62.9 79 2.0 - - - - 2683 64.4 68 1.6 - - - - 
Missing - - 11 0.3 3 0.1 - - - - 14 0.3 15 0.4 - - - - 
Never / Former - - 3319 84.1 195 4.9 - - - - 3,606 86.6 170 4.1 - - - - 
Current smoker - - 389 9.9 30 0.8 - - - - 339 8.1 18 0.4 - - - - 
Missing - - 10 0.3 4 0.1 - - - - 17 0.4 14 0.3 - - - - 
Not obese - - 2229 56.5 101 2.6 - - - - 2195 52.7 57 1.4 - - - - 
Obese - - 432 10.9 13 0.3 - - - - 640 15.4 12 0.3 - - - - 
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Missing 1057 26.8 115 2.9 - - - - 1127 27.1 133 3.2 - - - - 
Active - - 973 24.7 85 2.2 - - - - 1032 24.8 65 1.6 - - - - 
Inactive - - 830 21.0 86 2.2 - - - - 1040 25.0 82 2.0 - - - - 
Missing 1915 48.5 58 1.5 - - - - 1890 45.4 55 1.3 - - - - 
1st Follow-up 3.7 1.2 2730 69.2 159 4.0 566 14.3 492 12.5 2969 71.3 159 3.8 412 9.9 624 15.0 
2nd Follow-up 7.4 0.9 479 12.1 75 1.9 1034 26.2 2359 59.8 629 15.1 80 1.9 745 17.9 2710 65.1 
3rd Follow-up 11.1 0.7   196 5.0 67 1.7 1348 34.2 2336 59.2   294 7.1 70 1.7 948 22.8 2852 68.5 
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 Table 3 Total Life Expectancies (TLE) and life expectancy free of cognitive impairment (CIFLE) and with cognitive impairment (CILE) in 
years (standard errors in parentheses), and as a proportion of TLE by individual risk factor (smoking, obesity, physical inactivity) for males and 
females with high education at age  65, weighted to the 1996 estimated resident population of Australia. 
 
TLE CIFLE CILE 
Risk factor Years (SE) Years (SE) %1 Years (SE) %1 
Males                   
Smoking Yes 13.48 0.66 12.32 0.64 91.4 1.16 0.40 8.6 
  No 17.30 0.33 15.27 0.29 88.3 2.03 0.21 11.7 
  Gain(+) or loss(-) with no risk factor 3.82 0.74 2.95 0.70   0.87 0.45   
Obesity Yes 16.95 0.83 15.02 0.79 88.6 1.93 0.51 11.4 
  No 17.57 0.45 15.96 0.45 90.8 1.61 0.21 9.2 
  Gain(+) or loss(-) with no risk factor 0.62 0.94 0.94 0.79   -0.32 0.55   
Inactive Yes 15.52 0.50 13.91 0.47 89.6 1.61 0.24 10.4 
  No 18.02 0.55 15.45 0.52 85.7 2.56 0.34 14.2 
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  Gain(+) or loss(-) with no risk factor 2.50 0.74 1.54 0.70   0.95 0.42   
Females               
Smoking Yes 15.49 0.88 14.25 0.82 92.0 1.24 0.48 8.0 
  No 21.37 0.41 18.85 0.36 88.2 2.53 0.31 11.8 
  Gain(+) or loss(-) with no risk factor 5.88 0.97 4.60 0.90   1.29 0.57   
Obesity Yes 18.97 0.76 17.52 0.75 92.4 1.45 0.31 7.6 
  No 20.69 0.53 18.63 0.49 90.0 2.06 0.27 10.0 
  Gain(+) or loss(-) with no risk factor 1.72 0.93 1.11 0.90   0.61 0.41   
Inactive Yes 19.37 0.54 17.63 0.52 91.0 1.74 0.25 9.0 
  No 22.26 0.71 18.78 0.55 84.4 3.47 0.52 15.6 
  Gain(+) or loss(-) with no risk factor 2.89 0.89 1.15 0.76   1.73 0.58   
 1Proportion of TLE  
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Table 4 Total Life Expectancies (TLE) and life expectancy free of cognitive impairment (CIFLE) and with cognitive impairment (CILE)  
 TLE    CIFLE     CILE     
Number of risky behaviours Years (SE) p Years (SE) % p Years (SE) % p 
Males low education                       
2+ 13.12 0.72   11.85 0.66 90.32   1.27 0.37 9.68   
1 15.57 0.44   13.85 0.41 88.95   1.72 0.23 11.05   
None 17.25 0.47   14.95 0.39 86.67   2.31 0.29 13.39   
Gain (+) or loss (-) for  none v 2+ risky 
behaviours 
4.13 0.86 <0.0001 3.10 0.77   0.0001 1.04 0.47   0.03 
Males high education                       
2+ 14.03 0.79   12.86 0.72 91.66   1.17 0.35 8.34   
1 16.74 0.42   15.22 0.39 90.92   1.53 0.21 9.14   
None 18.30 0.40   16.17 0.35 88.36   2.13 0.26 11.64   
Gain (+) or loss (-) for  none v 2+ risky 
behaviours 
4.27 0.89 <0.0001 3.31 0.80   <0.0001 0.96 0.44   0.03 
            
Females low education                       
2+ 16.96 0.97   14.78 0.84 87.15   2.18 0.54 12.85   
1 18.94 0.52   16.11 0.46 85.06   2.83 0.31 14.94   
None 22.90 0.62   18.27 0.46 79.78   4.64 0.51 20.26   
Gain (+) or loss (-) for  none v 2+ risky 
behaviours 
5.94 1.15 <0.0001 3.49 0.96  0.0003 2.46 0.74  0.0009 
Cognitive impairment free life expectancy  26 
Females high education                       
2+ 17.88 0.89   16.64 0.83 93.06   1.24 0.37 6.94   
1 19.70 0.49   18.02 0.47 91.47   1.67 0.22 8.48   
None 22.89 0.49   20.10 0.43 87.81   2.80 0.32 12.23   
Gain (+) or loss (-) for  none v 2+ risky 
behaviours 
5.01 1.02 <0.0001 3.46 0.93   0.0002 1.56 0.49   0.0014 
Note: 1Proportion of TLE. Results are shown in years (standard errors in parentheses) and as a proportion of TLE by total number of risk factors (smoking, 
obesity, physical inactivity) for males and females at age 65 by level of education, weighted to the 1996 estimated resident population of Australia.
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Supplementary Table 1  
Total Life Expectancies (TLE) and life expectancy free of cognitive impairment 
(CIFLE) and with cognitive impairment (CILE) in years (standard errors in 
parentheses), and as a proportion of TLE for males (n = 3947) and females (n=4164) 
at ages 60, 65, 70, 75, 80, 85, 90, and 95 weighted to the 1996 estimated resident 
population of Australia. 
 
 TLE  CIFLE   CILE   
Age Years (SE) Years SE %1 Years SE %1 
Males                 
60 21.11 0.26 19.2 0.21 90.95 1.92 0.07 9.10 
65 17.04 0.34 15.17 0.3 89.03 1.87 0.15 10.97 
70 13.52 0.19 11.57 0.21 85.58 1.95 0.14 14.42 
75 10.26 0.23 8.34 0.21 81.29 1.91 0.14 18.62 
80 7.66 0.14 5.64 0.15 73.63 2.02 0.17 26.37 
85 5.64 0.16 3.51 0.13 62.23 2.13 0.11 37.77 
90 4.25 0.19 1.89 0.08 44.47 2.36 0.17 55.53 
95 3.32 0.33 0.88 0.04 26.51 2.44 0.34 73.49 
Females                 
60 25.52 0.49 22.61 0.29 88.60 2.90 0.26 11.36 
65 21.14 0.24 18.20 0.23 86.09 2.95 0.17 13.95 
70 17.23 0.21 14.28 0.20 82.88 2.96 0.19 17.18 
75 13.52 0.27 10.51 0.23 77.74 3.01 0.15 22.26 
80 10.42 0.22 7.39 0.15 70.92 3.03 0.18 29.08 
85 7.83 0.23 4.74 0.13 60.54 3.09 0.21 39.46 
90 5.98 0.35 2.62 0.07 43.81 3.36 0.33 56.19 
95 4.42 0.26 1.26 0.1 28.51 3.16 0.30 71.49 
Note: 1Proportion of TLE  
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Supplementary Table 2 
 
Total Life Expectancies (TLE) and life expectancy free of cognitive impairment 
(CIFLE) and with cognitive impairment (CILE) in years (standard errors in 
parentheses), and as a proportion of TLE for males (n = 3947) and females (n=4164) 
at ages 60, 65, 70, 75, 80, 85, 90, and 95 weighted to the 1996 estimated resident 
population of Australia based on CFAS cut point ≤21/22+ (18). 
 
 TLE CIFLE CILE 
Age Years (SE) Years SE % Years SE % 
Males                 
60 20.99 0.29 19.2 0.28 91.33 1.82 0.16 8.67 
65 17.08 0.24 15.3 0.24 89.40 1.81 0.15 10.60 
70 13.53 0.20 11.8 0.18 87.29 1.73 0.15 12.79 
75 10.45 0.19 8.7 0.16 83.54 1.72 0.16 16.46 
80 7.86 0.19 6.1 0.15 77.86 1.74 0.17 22.14 
85 5.81 0.21 4.0 0.12 69.54 1.77 0.18 30.46 
90 4.3 0.24 2.4 0.09 56.28 1.88 0.23 43.72 
95 3.45 0.29 1.3 0.07 37.97 2.14 0.29 62.03 
Females                 
60 25.4 0.33 23.6 0.33 92.91 1.8 0.14 7.09 
65 21.15 0.24 19.38 0.26 91.63 1.77 0.15 8.37 
70 17.21 0.27 15.5 0.27 90.06 1.71 0.16 9.94 
75 13.62 0.22 11.9 0.21 87.37 1.72 0.13 12.63 
80 10.47 0.23 8.73 0.19 83.38 1.73 0.17 16.52 
85 7.73 0.20 6.00 0.19 77.62 1.73 0.16 22.38 
90 5.64 0.23 3.83 0.15 67.91 1.81 0.21 32.09 
95 4.14 0.27 2.17 0.12 52.42 1.97 0.27 47.58 
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Supplementary Table 3  
Total Life Expectancies (TLE) and life expectancy free of cognitive impairment 
(CIFLE) and with cognitive impairment (CILE) in years (standard errors in 
parentheses), and as a proportion of TLE by individual risk factor (smoking, obesity, 
physical inactivity) for males and females with low education at age  65, weighted to 
the 1996 estimated resident population of Australia. 
  TLE  CIFLE   CILE   
 Risk factor Years (SE) Years (SE) %1 Years (SE) %1
Males                   
Smoking Yes 12.42 0.65 11.25 0.59 90.6 1.17 0.41 9.4 
  No 16.39 0.21 14.30 0.33 87.2 2.09 0.21 12.8
  
Gain(+) or loss(-) 
with no risk factor 3.97 0.68 3.05 0.68   0.92 0.46   
Obesity Yes 14.86 0.76 13.15 0.69 88.5 1.71 0.44 11.5
  No 15.49 0.45 14.03 0.45 90.6 1.47 0.20 9.5 
  
Gain(+) or loss(-) 
with no risk factor 0.63 0.88 0.88 0.82   -0.24 0.48   
Inactive Yes 13.74 0.54 12.40 0.48 90.2 1.33 0.21 9.7 
  No 16.29 0.54 14.10 0.48 86.6 2.18 0.29 13.4
  
Gain(+) or loss(-) 
with no risk factor 2.55 0.76 1.70 0.68   0.85 0.36   
Females               
Smoking Yes 15.19 0.90 13.17 0.86 86.7 2.02 0.75 13.3
  No 20.91 0.51 17.08 0.37 81.7 3.83 0.37 18.3
  
Gain(+) or loss(-) 
with no risk factor 5.72 1.03 3.91 0.94   1.81 0.84   
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Obesity Yes 17.77 0.87 15.58 0.77 87.7 2.19 0.43 12.3
  No 19.89 0.58 16.73 0.50 84.1 3.16 0.38 15.9
  
Gain(+) or loss(-) 
with no risk factor 2.12 1.05 1.15 0.92   0.97 0.57   
Inactive Yes 18.61 0.57 15.98 0.53 85.9 2.63 0.32 14.1
  No 22.28 0.83 17.15 0.58 77.0 5.14 0.71 23.1
  
Gain(+) or loss(-) 
with no risk factor 3.67 1.01 1.17 0.79   2.51 0.78   
Note: 1Proportion of TLE  
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Figure 1 – males and females CLE for all ages  
 
 
